
ReposiTrak, Inc.
94
Recent developments include quarterly dividend declarations, strategic amendments with SPAR Group involving stock payments and promissory notes, and ongoing earnings call disclosures through 2026.
- The Board declared a quarterly cash dividend of $0.02 per share in June 2026, paid in August 2026, representing an annual yield of approximately 0.88% based on June 30, 2026 closing prices [S1].
- ReposiTrak amended its services agreement with SPAR Group in March 2026 to allow payment in cash, client stock, or a combination, and elected to receive payment in client stock valued at approximately $2.3 million in May 2026 [S1].
- In July 2026, the company entered into stock purchase agreements with William Bartels and WHB Services, Inc., involving issuance of approximately 4.7 million shares of client stock and a $2.57 million promissory note with 6% interest maturing in 2030 [S1].
- Recent earnings call transcripts and highlights from Q2, Q3, and Q4 2026 provide operational and financial insights [N2][N3][N4][N5][N8].
- The FDA extended the FSMA 204 compliance deadline to July 20, 2028, but adoption of traceability solutions continues to accelerate due to commercial and competitive pressures [S1].
- The company completed its Audit Management solution by June 2023, enhancing audit efficiency and accuracy [S1].
ReposiTrak, Inc. is a Nevada-based SaaS company specializing in a B2B e-commerce, compliance, traceability, and supply chain management platform. Its platform enables retailers, wholesalers, distributors, and suppliers to manage supply chain programs, compliance with food safety regulations such as FSMA, and improve ordering and forecasting efficiency. The company offers three main application suites: Compliance Management, Traceability Network (RTN), and Supply Chain Solutions, delivered via a cloud-based infrastructure. The RTN supports compliance with FDA's FSMA Section 204(d) traceability requirements for high-risk foods, facilitating the capture and sharing of Key Data Elements at Critical Tracking Events. Proprietary patent-pending technologies enhance data integrity and scalability. The company operates a hub and spoke business model, engaging retailers and wholesalers as hubs and their suppliers as spokes. Customers are primarily in the U.S. consumer retail sector including food, convenience stores, and general merchandise. Professional services include business analytics and integration consulting. The company maintains operations from a SSAE 16 - SOC2 certified third-party data center. Recent corporate developments include a name change from Park City Group, Inc. to ReposiTrak, Inc. in December 2023 and strategic agreements with SPAR Group involving stock payments and promissory notes. The FDA extended FSMA 204 compliance deadline to July 2028, but adoption of traceability solutions continues to accelerate due to commercial pressures. Financial snapshot as of September 30, 2026 shows strong liquidity and profitability metrics [S1][S2].
ReposiTrak, Inc. is a SaaS company providing a B2B platform for supply chain management, compliance, and traceability primarily in the U.S. consumer retail sector. The company offers three main product suites addressing compliance management, traceability network, and supply chain solutions. It operates a hub and spoke model engaging retailers and wholesalers as hubs and their suppliers as spokes. The company has developed proprietary patent-pending technologies to enhance traceability data integrity and scalability. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. As of September 30, 2026, the company reported $24.5 million in cash and equivalents, a current ratio of 3.98, net income of $1.53 million, and basic and diluted EPS of $0.08. Recent earnings call transcripts from Q2, Q3, and Q4 2026 provide additional operational insights. The company declared a quarterly dividend of $0.02 per share in June 2026. The FDA's FSMA 204 traceability rule and extended compliance deadline to July 2028 shape the regulatory environment. The company faces competition from larger software vendors and evolving regulatory demands [S1][S2][N2][N3][N4][N5][N6][N7][N8][N1].
ReposiTrak's comprehensive SaaS platform addresses critical regulatory compliance and traceability needs in the food retail supply chain, a market influenced by evolving FDA regulations such as FSMA 204. The company's patent-pending technologies for data integrity and scalable traceability records enhance its competitive differentiation. Its hub and spoke model facilitates broad network adoption among retailers, wholesalers, and suppliers. Recent earnings call disclosures indicate operational progress and financial profitability. The company's liquidity position and dividend payments reflect financial stability. Accelerating adoption of traceability solutions driven by regulatory and commercial pressures supports ongoing demand for its offerings [S1][N2][N3].
ReposiTrak faces competition from larger software vendors with greater resources and sales capabilities. The regulatory environment, while driving demand, also introduces compliance risks and potential costs. The company's revenue data is limited in recent disclosures, and reliance on a concentrated customer base in the U.S. consumer retail sector may limit diversification. The company's financial disclosures show modest net income and EPS, and dividend payments are subject to board discretion. Market adoption of traceability solutions may be uneven, and technological or operational challenges could impact execution. The company's agreements involving stock payments and promissory notes introduce financial obligations and risks [S1][S2].
ReposiTrak's moat is supported by its specialized SaaS platform tailored for supply chain compliance and traceability in the food retail sector, addressing complex regulatory requirements such as FSMA 204. Its proprietary patent-pending technologies for automated error correction and scalable traceability data generation differentiate its offering. The company's hub and spoke business model leverages relationships with retailers and wholesalers to onboard suppliers, creating network effects. Long-standing industry relationships, a comprehensive product suite aligned with regulatory mandates, and professional services for integration further strengthen customer retention and competitive positioning. While competitors include larger software vendors, ReposiTrak's deep industry knowledge, regulatory focus, and patented technology provide barriers to entry and switching costs for customers [S1].
• Regulatory Compliance Risk: Changes or delays in regulatory requirements such as FSMA 204 could impact demand for the company's traceability solutions or require costly adjustments.
• Competitive Risk: Competition from larger software vendors with more extensive resources could pressure market share and pricing.
• Customer Concentration and Market Risk: The company's customer base is primarily in the U.S. consumer retail sector, which may limit diversification and expose it to sector-specific risks.
• Financial and Credit Risk: The company's financial obligations including promissory notes and contingent consideration introduce credit and liquidity risks.
• Technology and Execution Risk: Development and deployment of proprietary technologies and integration with customer systems carry execution risks that could affect product adoption and satisfaction.
Business trends: Increasing regulatory requirements for food traceability and compliance are driving demand for scalable SaaS solutions like ReposiTrak's platform.
Execution milestones: Continued deployment of proprietary patent-pending technologies, expansion of the Traceability Network, and integration of Audit Management solutions.
Key risks: Regulatory changes, competitive pressures from larger vendors, execution risks in technology deployment, and financial obligations related to stock agreements and promissory notes.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- ReposiTrak, Inc. is a Software-as-a-Service (SaaS) company operating a B2B e-commerce, compliance, traceability, and supply chain management platform.
- The platform serves retailers, wholesalers, distributors, and their suppliers to manage supply chain programs, compliance documents, and improve product ordering and forecasting.
- The company offers three main application suites: Compliance Management, Traceability Network (RTN), and Supply Chain Solutions.
- ReposiTrak's RTN supports compliance with FDA's FSMA Section 204(d) traceability requirements for high-risk foods, capturing and sharing Key Data Elements at Critical Tracking Events.
- The company has developed proprietary, patent-pending technologies for automated error detection and correction in traceability data and for generating compliant traceability records without case-level scanning.
- ReposiTrak's customers are primarily in the U.S. consumer retail sector including food, convenience stores, and general merchandise, but solutions are applicable to other sectors.
- The company operates a hub and spoke business model engaging retailers and wholesalers as hubs and their suppliers as spokes.
- Professional services include business analytics and integration consulting to support solution adoption.
- The company serves customers from a third-party SSAE 16 - SOC2 certified data center with security and backup measures.
- No single customer accounted for more than 10% of total revenue for fiscal year ended June 30, 2026.
- The company declared a quarterly cash dividend of $0.02 per share in June 2026, equivalent to $0.08 annually, with future dividends subject to board discretion.
- ReposiTrak entered into amended agreements with SPAR Group, including stock payment options and a promissory note with interest and maturity terms.
- The FDA extended the FSMA 204 compliance deadline to July 20, 2028, but commercial and competitive pressures are accelerating traceability adoption.
- The company completed its Supply Chain and Compliance and Food Safety solutions by June 2020 and Audit Management solution by June 2023.
- The company changed its corporate name from Park City Group, Inc. to ReposiTrak, Inc. in December 2023.
- Financial snapshot as of September 30, 2026: cash and equivalents $24.5M, current assets $30.4M, current liabilities $7.6M, current ratio 3.98, cash ratio 3.73.
- Net income for the quarter ended September 30, 2026 was $1.53M with basic and diluted EPS of $0.08.
- Revenue figure available from 2021 was approximately $21M, but more recent revenue data is not disclosed.
- Recent earnings call transcripts and highlights from Q2, Q3, and Q4 2026 provide operational and financial details.
- The company faces competitive pressures from larger software vendors and evolving regulatory requirements in food safety and traceability.
Generated 2026-11-17
- N2
- N4
- N5
- N8
- S1
- S1 | 2026-09-28 | 10-K
- S2 | 2026-11-16 | 10-Q
- N1 | 2026-10-29 | www.nasdaq.com | RSI Alert: ReposiTrak Now Oversold | https://www.nasdaq.com/articles/rsi-alert-repositrak-now-oversold
- N2 | 2026-09-29 | www.nasdaq.com | ReposiTrak (TRAK) Q4 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/repositrak-trak-q4-2026-earnings-call-transcript
- N3 | 2026-09-28 | www.nasdaq.com | ReposiTrak Q4 Earnings Call Highlights | https://www.nasdaq.com/articles/repositrak-q4-earnings-call-highlights
- N4 | 2026-05-15 | www.nasdaq.com | ReposiTrak Q3 Earnings Call Highlights | https://www.nasdaq.com/articles/repositrak-q3-earnings-call-highlights
- N5 | 2026-05-14 | www.nasdaq.com | ReposiTrak (TRAK) Q3 2026 Earnings Transcript | https://www.nasdaq.com/articles/repositrak-trak-q3-2026-earnings-transcript
- N6 | 2026-03-30 | www.nasdaq.com | Reminder - ReposiTrak (TRAK) Goes Ex-Dividend Soon | https://www.nasdaq.com/articles/reminder-repositrak-trak-goes-ex-dividend-soon
- N7 | 2026-03-23 | www.nasdaq.com | Daily Dividend Report: SLG,EBF,MTR,TRAK | https://www.nasdaq.com/articles/daily-dividend-report-slgebfmtrtrak
- N8 | 2026-02-18 | www.nasdaq.com | ReposiTrak, Inc. Q2 Profit Rises | https://www.nasdaq.com/articles/repositrak-inc-q2-profit-rises
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


